Dornase alfa vs mannitol
QoL · children with cystic fibrosis
Dornase alfa may leads to higher change in quality of life ‐ CFQ‐R at 3 months compared with mannitol (low certainty).
1 finding from 1 review
- MD 10.61 [0.27, 20.95]231 participantsLow
Dornase alfa may leads to higher change in quality of life ‐ CFQ‐R at 3 months compared with mannitol (low certainty).
Dornase alfa may leads to higher change in quality of life ‐ CFQ‐R at 3 months compared with dornase alfa and mannitol (low certainty).